Pazopanib in pretreated advanced neuroendocrine tumors: A phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

  1. Grande, E.
  2. Capdevila, J.
  3. Castellano, D.
  4. Teulé, A.
  5. Durán, I.
  6. Fuster, J.
  7. Sevilla, I.
  8. Escudero, P.
  9. Sastre, J.
  10. García-Donas, J.
  11. Casanovas, O.
  12. Earl, J.
  13. Ortega, L.
  14. Apellaniz-Ruiz, M.
  15. Rodriguez-Antona, C.
  16. Alonso-Gordoa, T.
  17. Díez, J.J.
  18. Carrato, A.
  19. García-Carbonero, R.
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2015

Volumen: 26

Número: 9

Pages: 1987-1993

Type: Article

DOI: 10.1093/ANNONC/MDV252 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus